Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

DYNAMICS OF HEMOPOIETIC PROLIFERATION IN MAN AND MICE STUDIED BY $sup 3$H- THYMIDINE INCORPORATION INTO DNA

Technical Report ·
OSTI ID:4308743

human being with normal and abnormal hematopoiesis to study the kinetics of bone marrow cell proliferation. Thymidine is taken up by the nucleus only during DNA synthesis preparatory to cell division. Its intracellular location was determined and quantified by means of stripping film autoradiography and classical cytology. In the bone marrow of human beings with normal hemlabeling of primitive proliferating cells was seen within minutes. Maximal labeling of erythorocyte precursors the 3rd and 4td day. Maximal labeling of megakaryocytes was observed on the 5th day. Early labeling in the peripheral blood of large mononuclear cells occured early; the peak labeling of granulocytes occured on the 5th to 6th day. H/sup 3/ thymidine incubated with normal series; normal venous blood showed labeling only of a tern of H/sup 3/ thymidine uptake with in vitro incubation of bone marrow and venous blood from patients varied with different hematopoietic disorders. A preliminary analysis of the quantitative results in terms of the kinetics of hematopoietic cell proliferation in health and disease is made, and the requirements for resolution of the complex probelms involved are pointed out. (auth)

Research Organization:
Brookhaven National Lab., Upton, N.Y.; National Institutes of Health, Bethesda, Md.
NSA Number:
NSA-12-014565
OSTI ID:
4308743
Report Number(s):
A/CONF.15/P/840
Country of Publication:
Country unknown/Code not available
Language:
English